Introduction
Methods
Literature Search Strategy
Eligibility Criteria
Data Extraction
Assessment of Methodological Quality
Statistical Analysis
Results
Treatment option | Studies (n) | Study characteristics | Patient characteristics | Intervention description | Adverse effects | Adherence |
---|---|---|---|---|---|---|
Behaviour | 8 | • 3 multicentre studies • 4 studies in USA, remaining in Australia, Netherlands, Sweden or New Zealand • Study duration varied between 6 and 24 months | • 2287 total patients • Mean age 4.8–13.23 years | • 5 studies had family based interventions • Interventions included motivational interviews, internet interventions, lifestyle advice sessions • Controls were untreated or underwent minimal intervention | • No adverse effects | • 2 studies commented • 50% compliance for completing 2 out of 6 sessions |
Exercise | 6 | • 2 studies in USA, remaining in Brazil, Canada, Norway or New Zealand • Study duration varied between 6 and 12 months | • 738 total patients • Mean age 7.56–15.9 years | • 3 studies were community based, 2 studies were school-based • Intervention varied from active video games to weekly aerobic sessions •Controls were untreated or given healthcare education | • No adverse effects | • Ranged between 58 and 62% |
Diet | 3 | • All single centred • Study duration varied between 4 and 12 months | • 111 total patients • Mean age 8.2–16.9 years | • Interventions included low glycaemic index diet, low fat diet or reduction in calories. | • No adverse effects | • Compliance varied between 22.2–57.3% • Motivation and parental support were related to poor compliance |
Behaviour, exercise and diet | 10 | • 2 in Germany, 2 in Mexico, 2 in USA, remaining in Finland, Australia, Netherlands and UK • 1 multicentre study • Study duration varied between 6 and 18 months | • 1875 total patients • Mean age 7.4–12.4 years | • 7 studies had family based interventions • All interventions contained behaviour, exercise and dietary aspects | • No adverse effects | • Varied adherence rates • Ranged from 53 to 94% |
Metformin | 14 | • 3 multicentre studies • 7 studies in USA, 2 in Canada, remaining in Australia, Germany, Iran, Mexico or UK • Study duration varied between 3 and 22 months | • 1145 (522 male) total patients • Mean age 10.1–15.7 years • Baseline mean BMI 25.4-41 kg/m2 | • 7 studies included lifestyle intervention in control and treatment groups • Metformin doses varied between 1000 and 2000 mg/day | • No serious side effects reported • 11 studies mentioned gastrointestinal symptoms • 2 studies had drop-outs due to side effects • 3 studies reported fatigue as most common side effect | • 60–94% adherence |
Sibutramine | 4 | • All single centred • 2 studies in USA, remaining in Brazil or Mexico • Study duration varied between 3 and 6 months | • 177 total patients • Mean age 13.9–16.7 years • Baseline mean BMI 30.1–38.5 kg/m2 | • Lifestyles intervention in all control and treatment groups • Sibutramine doses varied between 10 and 15 mg/day | • No serious side effects reported • 2 studies reported changes in blood pressure and heart rate | • No studies commented |
Orlistat | 3 | • 1 multicentre study • Study duration varied between 3 and 12 months | • 622 (228 male) total patients • Mean age 12.5–15.8 years • Baseline mean BMI 31.2–41.7 kg/m2 | • Lifestyles intervention in all control and treatment groups • All orlistat doses 120 mg, 3 times a day | • 1 patient developed symptomatic cholelithiasis requiring a cholecystectomy • Many gastrointestinal symptoms from oily stool to faecal incontinence reported | • Poor adherence due to side effects |
Intragastric balloon | 7 | • 3 studies from peer-reviewed journal, 4 conference abstracts • Study duration varied between 6 and 24 months | • 104 (48 male) total patients • Mean age 13.89–18.5 years • Baseline BMI 30–55.4 kg/m2 | • All studies placed an intragastric balloon in the stomach endoscopically | • No major complications reported • Most common side effect was epigastric pain | • No studies commented |
Endobarrier | 1 | • 1 conference abstract • Study duration was 6 months | • 6 total patients • Mean age 18.2 years • Baseline mean BMI 44.7 kg/m2 | • Duodenal–jejunal bypass liner was placed endoscopically | • No major complications reported | • No comment from study |
LAGB | 12 | • 824 (339 male) total patients • Mean age 15.8–18.5 years • Baseline mean BMI 42.5–50 kg/m2 • All patients underwent psychological screening before enrolment | • 824 (339 male) total patients • Mean age 15.8–18.5 years • Baseline mean BMI 42.5–50 kg/m2 • All patients underwent psychological screening before enrolment | • 7 studies used LAP-BAND, 2 studies used only/mostly SAGB • 8 studies used pars flaccida approach • Mean operation time varied between 35 and 55.9 min | • 1 intraoperative complication; laparotomy conversion after gastric perforation during band positioning • 1 post-operative death at 46 months, acute haemorrhage after band removal • Most common complication: asymptomatic iron deficiency (23%) | • Good adherence to follow-up plans, 78% at 12 months • Finance and motivation were related to loss of follow-up |
RYGB | 12 | • 630 total patients • Mean age 13–21 years • Baseline mean BMI 35–69 kg/m2 • 9 studies screened patients for psychological issues | • 630 total patients • Mean age 13–21 years • Baseline mean BMI 35–69 kg/m2 • 9 studies screened patients for psychological issues | • 6 studies used a laparoscopic approach • 2 studies contained a control group | • No intraoperative complications • 2 post-operative deaths; 1 due to infectious colitis at 9 month, 1 due to cardiac failure at 5 months • Most common complication: hernia development (9%) | • Mixed results, 1 study found 75% adherence • 1 study found adolescents are equally as likely to deviate from follow-up plans as adults |
LSG | 9 | • 1099 total patients • Mean age 13.9–19 years • Baseline mean BMI 36–57 kg/m2 • 5 studies needed psychological assessment before enrolment | • 1099 total patients • Mean age 13.9–19 years • Baseline mean BMI 36–57 kg/m2 • 5 studies needed psychological assessment before enrolment | • 3 studies included a control group. These patients underwent lifestyle interventions | • No intraoperative complications reported • No reported mortality • Most common complication: gastroesophageal reflux (28%) | • 1 study commented • Adherence rate of over 70% to follow-up plans |
Study |
N
| Complications (number of cases) |
---|---|---|
Laparoscopic adjustable banding | ||
Holterman, A. X. (2010) | 20 | Tube/port issues (3), band malfunction (1), hiatal hernia (1) |
Khen-Dunlop, N. (2016) | 49 | Death (1), band slippage (1), psychological intolerance (1) |
Nadler, E. P. (2009) | 45 | Band slippage (2), asymptomatic iron deficiency (19) |
Nadler, E. P. (2007) | 53 | Band slippage (2), hiatal hernia (2), wound infection (1), reflux (1), mild hair loss (5), iron deficiency (4) |
Nadler, E. P. (2008) | 73 | Band slippage (4), hiatal hernia (3), wound infection (1), port leak (1), mild hair loss (14), iron deficiency (13), vitamin D deficiency (4), gastroesophageal reflux (3), cholelithiasis (2), nephrolithiasis (1) |
Silberhumer, G. R (2011) | 50 | Dislocated port (1) |
Silva, G. M. (2012) | 14 | Port Leakage (2), gallstone formation (1), micronephrolithiasis (1), gastroesophageal reflux (2), asymptomatic nutrient deficiency (2) |
Angrisani, L. (2005) | 58 | Band slippage (1), gastric pouch dilation (2), intragastric migrations (3), psychological intolerance of band (2), conversion to gastric bypass (1) |
Lanthaler, M. (2009) | 41 | Pouch dilations (11), band leakage (4), intragastric migration (2), port disconnection (2) |
Dillard, B. E. (2007) | 24 | Pouch enlargement (6), port leak (1) |
Laparoscopic sleeve gastrectomy | ||
Ahmed El-Matbouly, M (2017) | 91 | Endoscopic dilation due to stenosis (3) |
Alqahtani, A. R. (2016) | 274 | Wound infection (2), nausea and vomiting (2), possible staple line leak (1), staple line bleed (1), gastroesophageal reflux (4), metabolic neuropathy (2) |
Alqahtani, A. R. (2015) | 291 | Wound infection (2), nausea and vomiting (2), possible staple line leak (1), staple line bleed (1), gastroesophageal reflux (4), metabolic neuropathy (2) |
Nadler, E. P. (2012) | 23 | Cholelithiasis (1), postviral gastroparesis (2) |
Saleh M. Aldaqal (2013) | 32 | No complications occurred |
Dargan, D. (2017) | 208 | No complications occurred |
Dubnov−Raz, G. (2014) | 25 | Cholelithiasis (5), vitamin B1, C, D and folic acid deficiency (1) |
Alqahtani, A. R (2012) | 108 | Wound infection (2), possible staple leak (1), gastroesophageal reflux (3) |
Roux-en-Y gastric bypass | ||
Olbers, T. (2012) | 81 | Internal hernia (5), symptomatic gallstones (5), abdominal pain (5) |
Messiah, S. E. (2013) | 247 | Nausea, vomiting, intestinal bleeding, diarrhoea or gallstones (29), hernia (6), small bowel obstruction (2), wound infection (1), vitamin A, B12, D, folate, iron, magnesium, zinc, electrolytes deficiency (24), excess skin (3) |
Inge, T. H. (2015) | 22 | Dehydration (1) |
Inge, T. H. (2009) | 11 | Gastrointestinal leakage (1), small bowel obstruction (4), dehydration (1), gastrojejunal anastomotic stricture (1) |
Inge, Y. H. (2017) | 58 | Upper endoscopy (13), cholecystectomy (12), repair of gastrointestinal perforation (7), blood and micronutrient infusion (6) |
Teeple, E. A. (2012) | 15 | Ileus (1), port-site hernia (1), gastrojejunal anastomotic stricture bleed/leak (1) |
DuCoin, C. (2015) | 15 | Pouch dilation (1) |
Lawson, M. L. (2006) | 31 | Death (1), wound infection or anastomotic stricture, nausea, diarrhoea, dehydration, deep vein thrombosis or hypokalaemia (9), internal hernia (1), persistent iron deficiency or peripheral neuropathy secondary due to vitamin deficiency (6) |
Brissman, M. (2016) | 41 | No complications reported |
Cruz−Munoz, N. (2013) | 71 | Nausea and vomiting (2), iron deficiency (3) |
Lifestyle Modifications
Behaviour
Exercise
Diet
Behaviour, Exercise and Diet
Pharmacological Therapies
Metformin
Sibutramine
Orlistat
Endoscopic Treatments
Intragastric Balloon
Bariatric Surgery
Laparoscopic Adjustable Banding
Roux-en-Y Gastric Bypass
Laparoscopic Sleeve Gastrectomy
Discussion
Key Statistics
Lifestyle BMI (kg/m2) mean difference | − 0.99 (95%CI − 1.43 to − 0.53) |
Drugs BMI (kg/m2) mean difference | − 0.94 (95%CI − 1.30 to − 0.59) |
Surgery BMI (kg/m2) mean difference | − 14.04 (95%CI − 15.65 to − 12.43) |